Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumor in the United States - supplementary material

Supplementary Table 1. Distribution and comparison of ICD-10-CM diagnosis codes on the index date or during the minimum 6-month pre-index period1 in the pexidartinib cohort (N=82) and the other systemic therapy cohort indexed at any time (N=462).
Supplementary Table 2. Demographics and select baseline clinical characteristics of patients indexed on other systemic therapies for TGCT before August 2, 2019 (N=199).